ELISA to measure neutralizing capacity of anti-C1-inhibitor antibodies in plasma of angioedema patients

We have developed a robust, specific and semi-quantitative assay to detect the neutralizing capacity of plasma samples containing anti-C1-inh antibodies. This assay can be an important tool for the study of clinical implications of anti-C1-inh NAbs.